CLARISCAN 376.9 mg/mL (Gadoterate Meglumine INJECTION, SOLUTION) 376.9 mg/mL

Clariscan 376.9 mg/mL is a gadoterate meglumine injection used for contrast enhancement in MRI scans. This solution aids in visualizing internal structures for better diagnostic accuracy.

Strength

376.9 mg/mL

Pack Size

10 SYRINGE, PLASTIC in 1 BOX (0407-2943-22) / 20 mL in 1 SYRINGE, PLASTIC

Manufacturer / TM Owner

GE Healthcare

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Clariscan 376.9 mg/mL is primarily used as a contrast agent in magnetic resonance imaging (MRI). It helps to enhance the visibility of certain tissues and structures, making it easier for healthcare professionals to diagnose and monitor various conditions. This gadoterate meglumine injection is administered intravenously to improve the clarity of MRI images, aiding in the detection of abnormalities.

Side Effects

Common effects of Clariscan 376.9 mg/mL may include temporary discomfort at the injection site, such as pain or swelling. Some individuals might experience nausea or a metallic taste in the mouth. These effects are generally mild and short-lived. Always consult a healthcare provider for any persistent or severe reactions.

Precautions & Warnings

Clariscan 376.9 mg/mL should be used with caution in individuals with a history of allergic reactions to contrast agents. It is important to inform your healthcare provider about any existing medical conditions or allergies before administration. The solution should be handled and stored according to the manufacturer's guidelines to maintain its efficacy and safety.

Avoid Interactions

Clariscan 376.9 mg/mL may interact with certain medications or medical conditions. It is advisable to discuss all current medications and health conditions with a healthcare provider before using this contrast agent. Specific interactions with alcohol or other substances have not been widely documented, but general caution is recommended.

Frequently Asked Questions

Clariscan 376.9 mg/mL is used as a contrast agent to enhance the visibility of tissues and structures during MRI scans.

Clariscan 376.9 mg/mL is administered intravenously by a healthcare professional during an MRI procedure.

Common side effects may include temporary discomfort at the injection site, nausea, or a metallic taste in the mouth.

Individuals with a history of allergic reactions to contrast agents should use Clariscan 376.9 mg/mL with caution.

Clariscan 376.9 mg/mL should be stored according to the manufacturer's guidelines to maintain its efficacy and safety.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.